CCR2 and amyotrophic lateral sclerosis: Furthermore, a significant reduction of CD14+ and CCR2 expressing monocytes in ALS patients, particularly with less severe form of disease, has been suggested to drive the recruitment of activated monocytes CNS in the early stages of the disorder [14].